A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 104
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MT1
Long Form : membrane type 1
No. Year Title Co-occurring Abbreviation
1997 Expression of membrane type 1 matrix metalloproteinase in human articular cartilage. IL-1beta, MMP, mRNA, OA
1997 Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. EMT, HBC, MMP-2
2000 Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. T/N
2000 Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. MMPs
2000 Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. MMP2, TIMP2
2001 Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. HNSCCs, MMP, PCs
2001 Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. MMPs
2001 Extracellular matrix degradation and the role of hepatic stellate cells. HSCs, MMPs, uPA
2001 Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. pro-MMP, TIMP-2
10  2001 MT1-MMP in rat testicular development and the control of Sertoli cell proMMP-2 activation. ---
11  2001 Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. ECM, MMPs, NF-kappaB, OPN
12  2001 Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. MMPs
13  2001 Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. MMP, TIMPs
14  2002 Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. MMPs
15  2002 Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. MMPs
16  2002 Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. CCR, MCP, MMP
17  2002 Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype. APC, EGF, HGF, IMCE, MMP, YAMC
18  2002 Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. MMPs, TIMPs
19  2002 Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells. BB, eLC, iLC, LC, MMP-9, TNF-alpha
20  2002 Survivin gene expression in endometriosis. MMP
21  2002 Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry. Ln-5, MMPs
22  2002 The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. MMPs
23  2002 The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea. MMP
24  2003 Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors. MMPs, TIMP-2
25  2003 Gestational profile of matrix metalloproteinases in rat uterine artery. MMPs, TIMPs
26  2003 Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. IGF, IL, MMP-2
27  2003 Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells. Con A, EC, MMP, MSC, S1P
28  2003 Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. HMVECs, MMP-1, PCR, TIMP-1, VEGF
29  2003 Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection. MMP, TIMP
30  2003 Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. CAA, HCSM, MMP-2
31  2003 Temporal expression and activation of matrix metalloproteinases-2, -9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia. HI, MMP, PMNs
32  2003 The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells. MMPs, TIMPs
33  2003 TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. MMP, MMP-2, TIMP, TIMP-2
34  2004 Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent expression of MT1-MMP. MMPs, PI3K, SMC
35  2004 Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. MMPIs, MMPs
36  2004 Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells. MT1-MMP
37  2004 Experimental hindlimb ischemia leads to neutrophil-mediated increases in gastrocnemius MMP-2 and -9 activity: a potential mechanism for ischemia induced MMP activation. ANOVA, HI, MMP, ND, PMNs
38  2004 Gelatinase expression in ocular surface disorders. MMP, RT-PCR
39  2004 Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis. AJs, MMP, TIMP
40  2004 Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells. MMPs, RWPCs, VSMCs
41  2005 High-density lipoproteins prevent the oxidized low-density lipoprotein-induced epidermal [corrected] growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation. HDL, HNE, oxLDL, ROS
42  2005 How do stem cells find their way home? BM, ECM, LFA-1, SCF, SDF-1
43  2005 MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2. MMP
44  2005 Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing. ---
45  2006 Changes in matrix metalloproteinase 2 activities in amniochorions during premature rupture of membranes. ECM, MMPs, TIMP
46  2006 Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation. AAA, MMP, TIMP, TIMP-2
47  2006 Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast. DCIS
48  2006 Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice. MMP
49  2006 Intracellular localization of matrix metalloproteinases and their inhibitors in cultured tumor cell lines: flow cytometric analysis. MMPs, TIL
50  2006 Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. BM, CB, HGF, MMPs, MSCs, SDF, VE
51  2006 Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway. ERK, GM-CSF, HCMC, MEK, MMPs, PMA, TIMPs
52  2006 Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity. ---
53  2006 The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. DSS, EOC, MMP
54  2007 Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. MMPs, RT-PCR, TIMPs
55  2007 Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors. MMPs, TIMPs
56  2007 Differential expression of matrix metalloproteinases and inhibitors in developing rat lung mesenchymal and epithelial cells. AECs, ATII, MMPs, PN, TIMPs
57  2007 Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. COX-2, DHA, TCF
58  2007 Evidence for a cooperative role of gelatinase A and membrane type-1 matrix metalloproteinase during Xenopus laevis development. ECM, GelA, MMPs
59  2007 Immunohistochemical observation of amniotic membrane patching on a corneal alkali burn in vivo. alpha-SMA, AM, MMP
60  2007 Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia. big ET-1, CTT, MMP-2, PE
61  2007 Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. ADC, MMP, NSCLC, RECK, RT-PCR, SCC
62  2007 The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion. EMT, hMSC, MMPs
63  2008 Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation. MMP, VEGF
64  2008 Cocoa procyanidins inhibit expression and activation of MMP-2 in vascular smooth muscle cells by direct inhibition of MEK and MT1-MMP activities. CPF, MEK, MMP, VSMC
65  2008 Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells. EST, MMPs, PROG, RT-PCR, TIMP, VSMCs
66  2008 Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium. EMMPRIN, MMPs, TIMP
67  2008 JNK as a positive regulator of angiogenic potential in endothelial cells. JNK, MMP-2
68  2008 The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts. FLS, MMPs, RA
69  2008 The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP. MT1-MMP
70  2009 Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation. BSP
71  2009 Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard. MMPs, NHDF, SM
72  2009 MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices. MMP, SCITs
73  2009 Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice. alpha-SMA, MMP, PA, PF, TGF-beta1, TIMP, tPA
74  2009 Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells. ERK, MMP, PPARgamma, ROS, Trog, VEGF
75  2010 Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro. MMP2
76  2010 Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent. MMPs, rhTIMP-2, TIMP-2
77  2010 Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP. MT1-MMP, PC
78  2010 Prognostic value of membrane type 1 and 2 matrix metalloproteinase expression and gelatinase A activity in bladder cancer. MMPs
79  2010 The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells. BM, ECM, FACS, G-CSF, HGF, HSPCs, MMPs, PB, WBC
80  2010 The ss1-integrin-dependent function of RECK in physiologic and tumor angiogenesis. Cip1, HUVEC, MMP, RECK
81  2010 TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. ECM, MI, MMPs, TIMPs
82  2011 Exosite interactions impact matrix metalloproteinase collagen specificities. cat, cat, fTHPs, MMP
83  2011 Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/progenitor cells. CB, G-CSF, HSPC, MMPs, SDF
84  2011 Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. CRC, MMP2, VEGF
85  2011 Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor. COX-2, MMP-2
86  2011 Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. MMP, Rho, ROCK
87  2011 The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines. hMSCs, MMP
88  2012 Adenosine A3 receptor stimulation reduces muscle injury following physical trauma and is associated with alterations in the MMP/TIMP response. MMPs, TA
89  2012 All-trans-retinoic acid and the glycolipid alpha-galactosylceramide combined reduce breast tumor growth and lung metastasis in a 4T1 murine breast tumor model. alpha-GalCer, MMP, RA
90  2012 Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase. Con A, HAI-1, uPA
91  2012 Cyclosporine-A inhibits MMP-2 and -9 activities in the presence of Porphyromonas gingivalis lipopolysaccharide: an experiment in human gingival fibroblast and U937 macrophage co-culture. CsA, LPS
92  2012 Nascent vessel elongation rate is inversely related to diameter in in vitro angiogenesis. MMPs
93  2013 A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1-MMP. MMPs, MT, TIMP-2
94  2013 Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma. MMPs, RT-PCR, TIMPs
95  2013 MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells. COX, MMPs, PMA
96  2013 MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells. MMPs
97  2013 Quantitative FRET imaging to visualize the invasiveness of live breast cancer cells. FRET, MMPs
98  2014 EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma. EMMPRIN, MMPs, OS and DFS
99  2014 Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload. LV, MMPs, PO, WT
100  2014 Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation. GSK-3beta, MMP, PTEN
101  2014 The effect of imiquimod on matrix metalloproteinases and tissue inhibitors of metalloproteinases in malignant melanoma cell invasion. MMPs, TIMPs
102  2016 p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer. BM, DCIS
103  2018 Processed eggshell membrane powder regulates cellular functions and increase MMP-activity important in early wound healing processes. alpha-SMA, ESM, MMP-2, PEP, TIMP-2
104  2019 Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. AD, APP, BACE1, MMP